|
Volumn 19, Issue 3, 1993, Pages 181-191
|
A feasibility study on quantitating myocardial perfusion with Albunex®, an ultrasonic contrast agent
a a a b b |
Author keywords
Albunex ; Integrated backscatter; Myocardial perfusion; Ultrasonic scattering; Ultrasound; Ultrasound contrast agent
|
Indexed keywords
BACKSCATTERING;
CARDIOVASCULAR SYSTEM;
COMPUTER APPLICATIONS;
CONTRAST MEDIA;
DATA ACQUISITION;
HEMODYNAMICS;
INTERFACES (COMPUTER);
ULTRASONIC EQUIPMENT;
ALBUNEX;
INTEGRATED BACKSCATTER;
MYOCARDIAL PERFUSION;
ULTRASOUND CONTRAST AGENT;
ECHOCARDIOGRAPHY;
ALBUNEX;
ECHO CONTRAST MEDIUM;
MICROSPHERE;
ANIMAL TISSUE;
ARTICLE;
AUTORADIOGRAPHY;
BLOOD;
CLINICAL TRIAL;
COMPUTER INTERFACE;
CORONARY ARTERY;
ECHOCARDIOGRAPHY;
HEART LEFT VENTRICLE;
HEART MUSCLE;
HEART MUSCLE PERFUSION;
HEART SCINTISCANNING;
INTRACARDIAC DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LINEAR SYSTEM;
MICROCOMPUTER;
NONHUMAN;
ULTRASOUND;
VIDEODENSITOMETRY;
ALBUMINS;
ANIMAL;
CONTRAST MEDIA;
CORONARY CIRCULATION;
DOGS;
ECHOCARDIOGRAPHY;
FEASIBILITY STUDIES;
INJECTIONS, INTRAVENOUS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0027294808
PISSN: 03015629
EISSN: None
Source Type: Journal
DOI: 10.1016/0301-5629(93)90108-Z Document Type: Article |
Times cited : (35)
|
References (23)
|